Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
radiopharmaceutical
diagnostic agent |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
gptkb:V09AB03
|
| gptkbp:brand |
gptkb:DaTscan
|
| gptkbp:CASNumber |
155936-80-6
|
| gptkbp:chemicalFormula |
C18H23FIN2O2
|
| gptkbp:developedBy |
gptkb:GE_Healthcare
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:halfLife |
13 hours
|
| gptkbp:hasIsland |
gptkb:iodine-123
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ioflupane (123I)
|
| gptkbp:imagingTarget |
gptkb:dopamine_transporter
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:MeSH_ID |
C522831
|
| gptkbp:molecularWeight |
427.3 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2103837
160843 |
| gptkbp:sideEffect |
nausea
dizziness headache injection site pain |
| gptkbp:UNII |
6Z5B6HVF6O
|
| gptkbp:usedFor |
gptkb:SPECT_imaging
Parkinson's disease diagnosis differentiation of essential tremor from parkinsonian syndromes dopamine transporter imaging |
| gptkbp:bfsParent |
gptkb:DaTscan
|
| gptkbp:bfsLayer |
7
|